Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Bleomycin in Electrochemotherapy for Cutaneous Malignancies
NCT06647342Phase 4Recruiting
- Start
- Oct 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bleomycin in cutaneous malignancy, cutaneous metastasis (CM). Started Oct 2024; status: recruiting.
02
Drugs
bleomycin
03
Conditions
cutaneous malignancycutaneous metastasis (CM)
Beyond the preview
Go deeper on NCT06647342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06647342.